WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Completed
Location: See all (26) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• All patients for whom treatment with the Wingspan Stent System is considered.
Locations
United States
Alabama
University of Alabama-Birmingham
Birmingham
California
Sutter Eden Medical Center
Castro Valley
Cedars-Sinai Medical Center
Los Angeles
Southern California Permanente Medical Group
Los Angeles
UCSD Medical Center
San Diego
Santa Barbara Cottage Hospital
Santa Barbara
Florida
Mount Sinai Medical Center
Miami Beach
Georgia
Emory University, Grady Memorial Hospital
Atlanta
WellStar Health System
Marietta
Illinois
University of Chicago
Chicago
Cadence Health, Northwestern Medicine Central DuPage Hospital
Winfield
Kentucky
Baptist Health Lexington
Lexington
University of Kentucky Medical Center
Lexington
Massachusetts
University of Massachusetts, Worcester
Worcester
Michigan
St. John Hospital and Medical Center, Inc.
Detroit
Missouri
SSM DePaul Health Center
Bridgeton
New York
Columbia University Medical Center
New York
Ohio
University Hospital of Cincinnati
Cincinnati
Cleveland Clinic
Cleveland
Oregon
Oregon Health & Science University
Portland
Pennsylvania
Abington Memorial Hospital
Abington
Tennessee
Tennessee Interventional Associates
Chattanooga
Texas
Valley Baptist Harlingen
Harlingen
Virginia
Sentara Norfolk General Hospital
Norfolk
Washington
University of Washington, Harborview Medical Center
Seattle
Multicare Medical Center
Tacoma
Time Frame
Start Date: 2013-12
Completion Date: 2019-08
Participants
Target number of participants: 152
Treatments
Other: Wingspan Stent System
Placement of the Wingspan Stent
Authors
Ameer Hassan, Thomas Grobelny, Rishi Gupta, Basavaraj Ghodke, Justin Fraser, Richard D Fessler II, Steven Hoover, Andrew Ringer, Lei Feng, Michael Alexander, Blaise Baxter, John Chaloupka, Alois Zauner, Italo Linfante, Harish Shownkeen, Qaisar Shah, Ajit Puri, Brian Kott, Gary Nesbit, Gabor Toth, David Bonovich, Philip Meyers, Charles Prestigiacomo, Demetrius Lopes, John Agola, Peter Rasmussen, Jeffrey Farkas, Erol Veznedaroglu, Richard Callison, Abdulnasser Alhajeri, Raul Nogueira
Related Therapeutic Areas
Sponsors
Leads: Stryker Neurovascular